These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8430054)

  • 21. Studies on the percutaneous absorption of parathion and paraoxon. II. Distribution of 32P-labelled parathion within the skin.
    FREDRIKSSON T
    Acta Derm Venereol; 1961; 41():344-52. PubMed ID: 13894841
    [No Abstract]   [Full Text] [Related]  

  • 22. STUDIES ON THE PERCUTANEOUS ABSORPTION OF PARATHION AND PARAOXON. VI. IN VIVO DECOMPOSITION OF PARAOXON DURING THE EPIDERMAL PASSAGE.
    FREDRIKSSON T
    J Invest Dermatol; 1964 Jan; 42():37-40. PubMed ID: 14110913
    [No Abstract]   [Full Text] [Related]  

  • 23. Percutaneous absorption and dermal dose-cholinesterase response studies with parathion and carbaryl in the rat.
    Knaak JB; Yee K; Ackerman CR; Zweig G; Fry DM; Wilson BW
    Toxicol Appl Pharmacol; 1984 Nov; 76(2):252-63. PubMed ID: 6437015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microclimate next to the skin: influence on percutaneous absorption of caffeine (ex-vivo study).
    Lboutounne Y; Silva J; Pazart L; Bérard M; Muret P; Humbert P
    Skin Res Technol; 2014 Aug; 20(3):293-8. PubMed ID: 24329738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the percutaneous absorption of parathion and paraoxon. I. Hydrolysis and metabolism within the skin.
    FREDRIKSSON T; FARRIOR WL; WITTER RF
    Acta Derm Venereol; 1961; 41():335-43. PubMed ID: 13894840
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on the percutaneous absorption of parathion and paraoxon. V. Rate of absorption of paraoxon.
    FREDRIKSSON T
    J Invest Dermatol; 1962 Apr; 38():233-6. PubMed ID: 13894843
    [No Abstract]   [Full Text] [Related]  

  • 27. Surfactant effects on skin absorption of model organic chemicals: implications for dermal risk assessment studies.
    Riviere JE; Brooks JD; Yeatts JL; Koivisto EL
    J Toxicol Environ Health A; 2010; 73(11):725-37. PubMed ID: 20391115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A physiologically relevant pharmacokinetic model of xenobiotic percutaneous absorption utilizing the isolated perfused porcine skin flap.
    Williams PL; Carver MP; Riviere JE
    J Pharm Sci; 1990 Apr; 79(4):305-11. PubMed ID: 2352140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro percutaneous absorption models.
    Bronaugh RL
    Ann N Y Acad Sci; 2000; 919():188-91. PubMed ID: 11083108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of cold storage on in vitro human skin absorption of six 14C-radiolabeled environmental contaminants: benzo[a]pyrene, ethylene glycol, methyl parathion, naphthalene, nonyl phenol, and toluene.
    Moody RP; Yip A; Chu I
    J Toxicol Environ Health A; 2009; 72(8):505-17. PubMed ID: 19267311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolated perfused porcine skin flap systems.
    Riviere JE
    Pharm Biotechnol; 1996; 8():387-407. PubMed ID: 8791821
    [No Abstract]   [Full Text] [Related]  

  • 32. Prediction of human percutaneous absorption from in vitro and in vivo animal experiments.
    Yoshimatsu H; Ishii K; Konno Y; Satsukawa M; Yamashita S
    Int J Pharm; 2017 Dec; 534(1-2):348-355. PubMed ID: 29111099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro percutaneous penetration of methyl-parathion from a commercial formulation through the human skin.
    Sartorelli P; Aprea C; Bussani R; Novelli MT; Orsi D; Sciarra G
    Occup Environ Med; 1997 Jul; 54(7):524-5. PubMed ID: 9282131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiological changes in skin barrier function in relation to occlusion level, exposure time and climatic conditions.
    Schäfer P; Bewick-Sonntag C; Capri MG; Berardesca E
    Skin Pharmacol Appl Skin Physiol; 2002; 15(1):7-19. PubMed ID: 11803253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the role of formulation on parathion toxicity.
    Puga FR; Rodrigues MA
    Ecotoxicol Environ Saf; 1996 Oct; 35(1):38-40. PubMed ID: 8930503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of in vivo and in vitro percutaneous absorption with a mathematical model.
    Hostýnek JJ; Reifenrath WG; Melendres JL; Magee PS
    Curr Probl Dermatol; 1995; 22():139-45. PubMed ID: 7587315
    [No Abstract]   [Full Text] [Related]  

  • 37. Predicting percutaneous absorption.
    Riviere JE
    Acta Pharm Nord; 1992; 4(2):119-20. PubMed ID: 1388760
    [No Abstract]   [Full Text] [Related]  

  • 38. [Subacute parathion poisoning: importance of percutaneous absorption in occupational exposure and its prevention; study of a case of mass occupational poisoning].
    SASSI C; ZURLO N; BARTALINI E; METRICO L
    Med Lav; 1955 Apr; 46(4):251-69. PubMed ID: 13244073
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of neostigmine on the pharmacokinetics of intravenous parathion in rats.
    Hurh E; Lee EJ; Kim YG; Kim SY; Kim SH; Kim YC; Lee MG
    Res Commun Mol Pathol Pharmacol; 2000; 108(3-4):261-73. PubMed ID: 11913717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous penetration of [14C]parathion in the mouse: effect of anatomic region.
    Skinner CS; Kilgore WW
    J Toxicol Environ Health; 1982 Mar; 9(3):483-90. PubMed ID: 7097798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.